THE EFFECT OF METOCURINE AND METOCURINE-PANCURONIUM COMBINATION ON INTRAOCULAR PRESSURE

ANTHONY J. CUNNINGHAM, C. PATRICK KELLY, JAMES FARMER AND A. GARNER WATSON

ABSTRACT Maintenance of a normal to low intraocular pressure during ocular surgery is of critical importance. The prime considerations for anaesthetic management include adequate depth of anaesthesia, normal carbon dioxide and arterial oxygen tensions, stable cardiovascular status and avoidance of stimuli likely to raise central venous pressure. Non-depolarizing muscle relaxants are associated with a reduction in intraocular pressure. Metocurine, a non-depolarizing relaxant, formerly known as dimethyltubocurarine, has been recently reintroduced into clinical practice. Metocurine has been reported to be 1.8 times more potent than d-tubocurarine and has the clinically advantageous cardiovascular effects of stable heart rate and mean blood pressure with minimal associated histamine release. When combined with pancuronium, metocurine potentiates the neuromuscular blocking proper- ties, so that small doses of both drugs in combination produce effective neuromuscular block. This study was designed to assess the suitability of metocurine 0.3 mg-kg- and metocurine 0.08 mg kg- plus pancuronium 0.02 mg kg- as muscle relaxants for ocular surgery. The results demonstrated that metocurine and metocurine-pancuronium combina- tion in the above doses combined with sodium thiopentone 5 mg'kg-t produced ideal conditions for intubation of the trachea in 4.45 (---0.19 SE) minutes and 4.35 (-0.16 SE) minutes respectively. In both treatment groups intraocular pressure was reduced below control values and a pattern of intraocular pressure stability ideal for ocular surgery was obtained during the 10 minutes observation period. The delayed onset of sufficient paralysis for tracheal intubation - 4.45 (---0.19 SE) minutes for metocurine and 4.35 (• SE) minutes for the combination - makes these techniques unsuitable for emergency ocular surgery because of the long interval when the airway is unprotected.

KEY WORDS: EYE, intraocular pressure; NEUROMUSCULAR RELAXANTS, meto- curine, pancuronium.

THE PRIME considerations involved in the anaes- formerly known as dimethyltubocurarine,~ has thetic management of patients undergoing ocular been recently reintroduced into clinical practice. surgery are a stationary eye, for safe surgical A trimethylated derivative of d-tubocurarine, conditions; absence of coughing and vomiting metocurine has 1.8 times the potency of d-tubo- during and after operation; avoidance of eleva- curarine and in doses of 0.3 mg-kg-~ produces tions in intraocular pressure, which can cause 96.1 per cent mean twitch depression within 4.8 extrusion of globe contents; airway control and a --- 0.6 (SEM) minutes, 2 allowing easy tracheal stable cardiovascular system. The choice of intubation. In such doses, metocunne offers the is of paramount importance. clinically advantageous cardiovascular effects of The ideal muscle relaxant for ocular surgery stable heart rate and mean blood pressure and would be one that is potent, with a rapid onset, minimal associated histamine release. 3-6 appropriate duration of action, and readily rever- Combinations of metocurine and pancuro- sible. In addition, autonomic and cardiovascular nium ~otentiate the neuromuscular blocking ef- side-effects should be minimal. Metocurine, a fects,-so that administration of small doses of nondepolarizing neuromuscular blocking agent both drugs (pancuronium 0.018mg.kg -t plus metocurine 0.072mg-kg -l) produce clinically effective neuromuscular blockade, with stable Anthony J. Cunningham, M.B., B.Ch., haemodynamie parameters and rapid reversal of F.R.C.P.(C),* Department of Anaesthesia; C. Patrick neuromuscular blockade, s Kelly, M.D., Resident in Anaesthesia; James Farmer, This study was designed to examine the M.D., Resident in Ophthalmology; A. Garner effects of metocurine 0.3 mg.kg -~ and meto- Watson, M.D., F.R.C.S.(C), Professor and Head, Department of Ophthalmology; Ottawa Health curine 0.08mg.kg -1 plus pancuronium 0.02 Science Centre General Hospital, Ottawa, Ontario. mg'kg -~ combination on intraocular pressure *Present address: Dr. A.J. Cunningham, Depart- when used in association with thiopentone 5 ment of Anaesthesia, St. Vincent's Hospital, Elm mg.kg -1 and to assess their suitability as muscle Park, Dublin, Eire. relaxants for patients undergoing ocular surgery. 617 Can. Anaesth. Soc. J., vol. 29, no. 6, November 1982 618 CANADIAN ANAESTHETISTS' SOCIETY JOURNAL

METHODS Data collected The following data were collected for each Forty male and female subjects who had given patient: (1) age. (2) sex. (3) weight. (4) six informed consent and were undergoing elective intraocular pressure measurements (described minor surgical procedures were studied. The above). (5) time interval between relaxant ad- patients' ages ranged from 16-50 (mean age 35 ministration and complete peripheral nerve years -+2.0 SE). All patients were A.S.A. Class twitch suppression. (6) classification of vocal I or II and had no ocular disease. No patient had cord relaxation. renal, hepatic or neuromuscular disease, nor was any patient receiving known to affect RESULTS myoneural transmission. All subjects received a premedication of 0.2 mg-kg-' orally Age, sex, weight and ease of tracheal intuba- 90 minutes before operation. The patients were tion had no apparent effect on intraocular pres- alternately allocated to two treatment groups. sure in either treatment group. Intubation condi- tions were recorded as excellent in 15 out of 20 patients receiving metocurine and 17 out of 20 TREATMENTGROUP I patients receiving metocurine-paneuronium combination. The time interval between the (n-20) Anaesthesia was induced with sodium administration of metocurine 0.3 mg.kg-~ and thiopentone 5mg.kg -~ and metocurine 0.3 mg.kg -l . complete peripheral nerve twitch suppression was 4.45 --- 0.19 (SE) minutes, while the interval was 4.35 +- 0.16 (SE) minutes for the TREATMENT GROUP II metocurine-pancuronium combination. Mean intraocular pressure values (--_ SE) at (n-20) Anaesthesia was induced with sodium each time point for the two groups are displayed thiopentone 5mg.kg -1 and metocurine 0.08 in Table I. The values obtained at the five time mg'kg-~ plus pancuronium 0.02 mg.kg -1. points following induction are expressed as A Professional Instruments Company NS-2A differences from control (• SE) and also as peripheral nerve stimulator was used to stimulate percentage of control (--- SE). Following induc- the ulnar nerve. The time interval between tion with thiopentone 5 mg.kg -1 and metocurine relaxant administration and complete peripheral 0.3 mg'kg -~ intraocu]ar pressure decreased to 69 nerve twitch suppression was recorded for both per cent of control at two and four minutes and treatment groups and the degree of vocal cord remained below control during the 10 minutes relaxation at the time of tracheal intubation was observation period P < 0.05 (Figure 1). For classified as excellent, satisfactory, fair or poor patients induced with thiopentone 5 mg.kg -~ and using the criteria of Lund and Stovner. 9 metocurine 0.08mg.kg -~ plus pancuronium The conduct of anaesthesia was similar for 0.02 mg'kg -1 intraocular pressure decreased to both treatment groups. Following induction, 74 per cent of control at two minutes and 77 per anaesthesia was maintained with - cent of control at four minutes and remained oxygen 4:2 litres/min and 0.5 per cent , below control during the 10 minutes observation using a Bain non-rebreathing anaesthesia circuit. period P < 0.05 (Figure 2). When the patterns of Controlled ventilation was employed in all cases mean intraocular pressure values in the two and tracheal intubation was done when peripher- al nerve twitch response was completely abol- TABLE I ished. Blood pressure was recorded each minute MEAN INTRAOCULAR PRESSURE VALUES and the electrocardiogram was monitored con- stantly. Arterial blood gas analysis was done at 5 Group I Group II and 10 minutes following administration to Control 14.0 +- 1.1 12,6 -+ 1.0 ensure normocarbia and normal arterial oxy- 2 Min (A) -4.4 +- 0.6 -3,3 -+ 0.7 genation. (B) 69 -4- 4.0 74 +- 5,5 An ophthalmologist (J,F.) measured the intra- 4 Min (A) -4.4 -+ 0.9 -2,9 -+ 0.9 ocular pressure of each subject using a Perkins (B) 69 +- 6.5 77 + 7,0 hand-held appianation tonometer following the 6Min (A) -3.3 -- 1.3 -1.6 - 1,1 instillation of 0.5 per cent tetracaine in the left (B) 76 -+ 9,5 87 -'- 9,0 eye. Measurements were recorded at the follow- 8Min (A) -4.2--- 1.3 -3.1 -- 1,1 ing six time points: on arrival in the operating (B) 70 _i- 9.0 75 z 8.5 room (control) and every two minutes for a total 10 Min (A) -4.9 --- 1.2 -3.5 - 1.2 (B) 65 +- 9.0 72 - 8.5 of 10 minutes following administration of meto- curine and metocurine-pancuronium combina- (A) Post induction difference from Control -+ SE. tion (five measurements). (B) Per cent of Control -+ SE. CUNNtNGHAM, el 12[.: METOCURINE AND METOCUR1NE-PANCURONIUM 619

~ 100 stigmata of histamine release were noted in the metocurine group. The small dose metocurine- 80 pancuronium combination appears to offer the advantages of adequate neuromuscular block- ade, shorter duration of action and cardiovas- cular stability. 7 Whether the combination of low dose metocurine-pancuronium combination 6 4o exerts its action at a presynaptic or post-synaptic TREATMENT GROUP I (MFTOCURINE) site or both is uncertain. A likely possibility is 'o 20 CONTROL lOP 14.D (~+ 1.1 } mrnHg that of simultaneous pre- and post-synaptic receptor inhibition. Metocurine, like d- L I I I 1 tubocurarine, may exert a predominant pre- 2 4 6 8 lo T,ME(MINUTES) synaptic action of reduced acetyleholine release while pancuronium in low concentrations aI?- FIGURE l Treatment Group I (metecurine). Mean pears to exert only a post synaptic effect."2 control intraocular pressure mmHG --. SE and per cent difference from control. These two non-depolarizing relaxants have dif- ferent protein binding affinities, 13 so their use groups at the five time points following induc- in combination may alter the protein binding tion were assessed using a profile analysis properties of each drug so that more free un- technique,I~ the pattern of values were similar bound drug is available at the neuromuscular and coincident. junction. Maintenance of normal to low intraocular DISCUSSION pressure during intraocular surgery is of critical importance. If the eye is incised when the This study demonstrated that metocurine intraocular pressure is excessively high, the and metocurine-pancuronium combination with sudden decompression might cause rupture of a thiopentone are ideal muscle relaxants for pa- sclerotic long posterior ciliary artery and the tients undergoing elective ocular surgery. The resulting haemorrhage could lead to loss of the low dose metocurine-pancuronium combination eye.14 was as effective as metocurine alone in produc- Elevation oft_he intraocular pressure when the ing satisfactory conditions for intubation of the eye is open could lead to extrusion of uveal trachea. tissue, lens and vitreous. The two major cate- Metocurine 0.3 mg.kg-1 produced smooth in- gories of factors affecting intraocular pressure tubating conditions in 4.45 -+ 0.19 (SE) minutes during surgery are extraocular pressure sources while the metocurine 0.08 mg.kg-I plus pancu- and intraocular aqueous humour fluid dynamics. ronium 0.02 mg'kg-I produced similar smooth Extraocular pressure sources include the intubating conditions in 4.35 - 0.16 (SE) muscles surrounding the eye and orbit and minutes. Both treatment groups produced a central venous pressure. Contraction of the pattern of intraocular stability which is highly extraocular muscles and orbicularis oculi mus- desirable for patients undergoing ocular surgery. cles can increase intraocular pressure. The No undue hypotension (systolic blood pressure depolarizing relaxant succinylcholine raises reduction to less than 70 per cent of control) or intraocular pressure by producing a slow and prolonged tonic contraction of the extraocular

100 muscles.15 Increases in central venous pressure are transmitted directly to the eye, producing an elevation of episcleral venous pressure, which in turn impedes the aqueous humour outflow from the canal of Schlemm. The aqueous humour is a < clear fluid which fills the anterior and posterior z chambers. The volume of aqueous depends on 4o its rate of formation and its rate of outflow through the trabecular meshwork and Schlemms TREATMENT GROUP 11 canal. Intraocular pressure rises when there is 20 (METOCURINE-PANCURONIUM) CONTROL lOP 12.6 Id:- 1.0) mmHg increased aqueous production or decreased out- flow. Two-thirds of the aqueous is formed in the I I I I I 0 2 4 6 8 I0 posterior chamber by the epithelial cells of the TIME (MINUTES) ciliary body in an active secretory process FIGuP~ 2 Treatment Group II (metocurine-pan- utilizing carbonic anhydrase. The remaining euronium). Mean control intraocular pressure mmHG one-third of the aqueous is formed in the anterior +- SE and per cent difference from control. chamber by simple filtration through the anterior 62O CANADIAN ANAESTHETISTS' SOCIETY JOURNAL surface of the iris. 16 From an anaesthetic view- tion conditions and short duration of action. point, control of the factors affecting pressure on Following pretreatment with diazepam 0.1 mg. the eye and extraocular muscle tone pose the kg -1 and in combination with thiopentone 3- major challenges. Adequate depth of anaesthe- 5 mg'kg -1, succinylcholine will .Eroduce only sia, maintenance of normal carbon dioxide and minor rises in intraocular pressure ~ and this is a arterial oxygen tensions ~7 stable cardiovascular rational anaesthetic technique for the emergency status, avoidance of coughing and movement ocular surgery case. Other reports suggest that during operation will prevent vascular conges- the prior administration of the carbonic anhy- tion from increasing intraocular pressure. drase acetazolamide z4 or hexafluorenium z5 or Control of the state of extraocular muscle tone pretreatment with the non-deoolarizing agents through the use of neuromuscular blocking d-tubocurarine or gallamine 26 will inhibit the agents and the subsequent effect on intraocular rise in intraocular pressure produced by suc- pressure has been the subject of extensive cinylcholine. investigation reported in the literature. The The new neuromuscular blocking agents ORG unique structure of the extraocular muscle is NC45 (Norcuron), BW33A (Atracurium) and peculiar to this discussion. Two types of histo- BWA 444U currently under investigation offer logical structures have been identified (A) Fel- the exciting promise of shorter duration of derstruktur, which produces a slow tonic con- action, significant lack of cardiovascular effects traction when exposed to or de- and less cumulative tendency than the currently polarizing relaxants 18 and (B) Fibrillenstruktur, popular non-depolarizing relaxants. 27 Unfortun- which produces a twitch response. The effects of ately, in the initial clinical studies of the neuromuscular blocking agents on intraocular monoquaternary pancuronium homologue ORG pressure depend on their action on these two NC45, the major disappointing feature is that the muscles fibres. Succinylcholine, which has been drug, like the currently used non-depolarizing shown to produce intraocular pressure rises of relaxants, has a slow onset of neuromuscular 18 mmHg in normal unanaesthetized individu- blockade. Using an intubating dose of 0.02 mg. als, 19 in increasing doses produces an increase in kg -j, the onset time to 76 --- 6 per cent twitch extraocular muscle tension by its effect on the suppression was 6.0 -+ 0.31 minutes. 28 tonic Felderstruktur system. D-tubocurarine de- What is required for the emergency open eye presses the twitch response (Fibrillenstruktur) in case is a relaxant with the speed of onset of the the cat superior rectus muscle and lowers the depolarizing agent succinylcholine and the intra- intraocular pressure. 2o This is the likely mecha- ocular pressure reducing action of the non- nism of action of pancuronium 2j and metocurine depolarizing agents pancuronium and meto- and other non-depolarizing relaxants in lowering cunne. intraocular pressure. The anaesthetic technique of induction with ACKNOWLEDGEMENTS thiopentone and metocurine or metocurine- pancuronium combination, followed by con- The authors wish to ackowledge the valuable trolled ventilation with nitrous oxide/oxygen and assistance of Mrs. Georgia Roberts, M.Sc., who halothane 0.5 per cent, as employed in this did the statistical analysis, Dr. David S. Skene study, ensures optimal surgical conditions for for his valuable help and encouragement and ocular surgery - a stationary eye, absence Mrs. France Greenwood, who provided secre- of coughing and movement during operation, tarial services. stable cardiovascular status, airway control, adequate depth of anaesthesia, lowered intra- REFERENCES ocular pressure levels, appropriate duration of 1. SIOELTING, V.K. GP.AF, J.P. & VIEIRA, Z. Dimethyl neuromuscular blockade and easy reversibility ether of d-tubocurarine iodine as an adjunct to anaes- with anticholinesterases. thesia. Proc. Soc. Exp. Biol. Med. 69:565-566 (1948). The delayed onset of sufficient paralysis for 2. SAVAKESE, J.J., ALl, H.H. & ANTONtO, R.P. The clinical pharmacology of metocurine. Anesthesiology tracheal intubation - 4.45 + 0.19 (SE) minutes 47:277-284 (1977). for metocurine and 4.35 • 0.16 (SE) minutes for 3, HUGHES,R., INGRAM, G.S. & PAY'NE, J.P. Studies of the combination makes these anaesthetic tech- dimethyl tubocurarine in anaesthetized man. Br. J. niques unsuitable for emergency ocular surgery Anaesth. 48:969-973 (1976). 4. HUGHES,R. & CHAPPLE,D.I. Effects of non-depolariz- because of the long time interval when the ing neuromuscular blocking agents on peripheral auto- airway is unprotected. For such emergency nomic mechanisms in cat. Br. J. Anaesth. 48:59-67 open-eye, full stomach cases succinylcholine (1976). offers the advantages of rapid onset of relaxation 5. HUGHES, R. & CHAPPLE, D.J. Cardiovascular and neuromuscular effects of dimethyl tubocurarine in (the time interval from bolus administration of anaesthetized cats and rhesus monkeys. Br. ]'. Anaesth. 1 mg'kg -I succinylcholine to abolition of twitch 48:847-851 (1976). response is 63 --. 5.1 seconds 22) smooth intuba- 6. MCCuLLOUGH, L.S., STONE, W.A. • DELAUNOIS, CUNNINGHAM, et al.: METOCURINE AND METOCURINE-PANCURONIUM 621

A.L. The effect of dimcthyl tubocurarine iodine on 18. DtETERT, S.E. The demonstration of different types of cardiovascular parameters, post ganglionic sympathetic muscle fibres in human extraocular muscle by electron activity and histamine release. Anesth. Analg. (Cleve). microscopy and staining. Invest. Oph- 51: 554- 559 (1972). thalmol. 4:51-63 (1965). 7. LEBOWI'I'Z, P.W., RAMSEY, F.M., SAVARESE, J.J. & 19. HOFFMAN, H. & HOLZER, H. Die Wirkung von Mus- ALl, H.H. Potentiation of neuromuscular blockade in kelrelaxantien auf den intrankularen Dmek. Klin. man produced by combinations of pancuroniam and Monatsbl. Augenheilk. 123:1-16 (1953). metoeurine or pancuronium and d-tubocurarine. 20. KATZ, R.L. & EArriNGS, K.E. A comparison of the Anesth. Analg. 59:604-609 0980). effects of neuromuscular blocking agents and cholines- 8, LEBOWITZ, P.W., RAMSEY, F.M., SAVARESE, J.J., terase inhibitors on the tibialis anterior and superior ALl, H.H. & DE BROS, F.M. Combination of pancumn- rectus muscle of the eat. J. Pharmacoh Exp. Ther. 152: ium and metocurine: Neuromuscular and hemodynamic 304-312 (1966). advantages over pancuronium alone. Anesth. Analg. 21. LITWILLER, R.W., DIFAZ10, C.A. & RUSHIA, E.L. 60:12-17 (1981). Pancuronium and intraocular pressure. Anesthesiology 9. LUND, I. & STOVNER, J. Dose response curves for 42:750-752 (1975). tuboeurarine, alcuronium and pancuronium. Acta 22. CULLEN, D.J. The effect of pretreatment with non- Anaesthesiol. Seand. Suppl. 37:238 0970). depolarizing muscle relaxants on the neuromuscular 10. MORmSON, D.F. Multivariate Statistical Methods. 1st blocking action of sueeinyleholine. Anesthesiology 35: ed., Toronto, McGraw Hill Book Company (1967). 572-578 (1971). ll. GALINDO, A. The role of pre-junctional effects in 23. CUNNINGHAM, A.J., ALBERT, O., CAMERON, J. ~/. myoneural transmission. Anesthesiology 36:598-608 WATSON, A.G The effect of intravenous diazepam on (1972). rise of intraocular pressure following succinylcholine. 12. So, P.C., WEN-HUEY, L.S. & ROSEN, AD. Pre and Can. Anaesth. Soc. J. 28:591-596 (1981). postsynaptic effects of pancuronium at the neuromus- 24. CARBALLO, A.S. Succiuylcholine and acetazolamide cular junction of the mouse. Anesthesiology 50: 199- (Diamox) in anaesthesia for ocular surgery. Can. 204 (1974). Anaesth. Soc. J. 12:486-498 (1965). 13. STOVNER, J., THEODORSEN, L. & BJELKE, E. Sensitiv- 25. KATZ, R,L., EAKINS, K.E. & LORD, C.O. The effect of ity tO dimethyltubocurarine and toxiferene with special hexafluorenium in preventing the increase in intraoeular reference to serum proteins. Bri. J. Anaesth. 44: pressure produced by succinylcholine. Anesthesiology 374-380 (1972). 29:70-78 (1968). 14. DUNCALF, D. Anaesthesia and intraocular pressure. 26. MILLER,R.D., WAY, W.L. ~e HICKEY, R.F. Inhibition Bull. N. Y. Acad. Med. 51:374-379 (1975). of succinylcholine induced intraocular pressure by 15. LINCOFF, H.A., ELLIS, C.H. & DE VOE, A.G. The non-depolarizing muscle relaxants. Anaesthesiology effect of succinylcholineon intraocular pressure. Am. J. 29:123-126 (1968). Ophthalmol. 40:501-510 (1955). 27. SAVARESE,J.J. The Dew neuromuscular blocking drugs 16. Anaesthesia in Ophthalmology: International Ophthal- are here. Anesthesiology 55:I-3 (1981). mology Clinics. R.B. Smith, (Ed.) Boston, Little, 28. FAHEY, M.R., MoRms, R.B., MILLER, R.D., SOHN, Brown, Aboul-Eish, E.: Physiology of the eye pertinent Y.J., CRONNELLY, R. & GENCARELLI, P. Clinical to anaesthesia, vol 13:1-18 (1973). Pharmacology of ORG NC 45 (Norcuron). A new 17. DUNCALF, D. & WEITZNEI~, S.W. The influence of nondepolarizing muscle relaxant. Anesthesiology 55: ventilation and hypercapnia on intraocular pressure 6-11 (1981). during anaesthesia. Anesth. Analg. (Cleve). 42: 232- 237 (1963).

R~SUM~ La chhurgie oculaire nEcessite le maintien de pressions intraoculaires basses ou normales. Une bonne conduite anesth6sique inclut une profondeur suffisante, une normocarbie et une oxygenation adequate, un Etat eardiovas-culaire stable et la prevention de tout stimulus susceptible d'augmenter la pression veineuse centrale. Les antid~polafisants ont l'avantage de produire une baisse de la pression intraoculaire. La mrtocurine, agent antid~polarisant connu aussi sous le nom de dimrthyltubocurarine a rrcemment EtE rrintroduite en anesthEsie. La mrtoeurine est 1.8 fois plus puissante que la d-tubocurarine tout en procurant des brnEfices cardiovasculaires certains: stabilit6 de la frrquence eardiaque et de la pression artrrielle moyenne avec drcharge minime d'histamine. Lorsqu'on l'associe au pancuro- nium, la mEtocurine potentialise le bloquage musculaire de sorte que de petites doses des deux produits peuvent produire une myorrsolution efficace. Cette Etude a Et6 con~ue pour Evaluer l'efficacitE de doses de mEtocurine 0.3 mg'kg-let 0.08 mg'kg-I assoicEes au paneurnnium 0.02mg.kg -l comme myorelaxants pendant la chirurgie oculaire. Les r~sultats out d~montr6 que la mrtocurine et l'association mrtocurine-pancuronium aux doses drift mentionnres avec thiopentone 5 mg.kg -I produisent des conditions idrales pour I'intubation en 4.45 (+- 19 SE) minutes et 4.53 (4-16 SE) minutes respectivement. Dans les deux groupes, la tension intra-oculaire a EtE rEduire sous le niveau des valeurs de eontrrle et un Etat de stabilit6 tensionnelle intraoculaire idEale pour la chirurgie oculaire a EtE obtenue pendant la pEriode d'observation de 10 minutes. Le d6lai n6cessaire a I'obtention d'une paralysie suffisante pour I'intubation trach6ale, 4.45 (-O. 19SE) minutes pour le mrtoeurine et 4.35 (+-9.16 SE) minutes pour l'association des deux antid~polarisants, rend ces techniques inadrquates pour la chirurgie oculaire d'urgence ~t cause de la longueur de l'intervalle au cours duquel les voles respiratoires restent sans protection.